Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Mapping the genome of a fetus from its mother’s blood could mean less risky screening for prenatal diseases.
Whatever the outcome of the ACLU vs. Myriad case, a new effort is needed to turn genetic testing into a useful diagnostic tool.
A gene-screening method can predict an individual’s response to cancer drugs.